Where is Finnrick located?

Finnrick is headquartered in Austin, United States.

Is Finnrick a funded company?

Finnrick is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Finnrick rank among its competitors?

Finnrick ranks 328th amongst 336 active competitors, of which 15 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was NCIMB, which secured $2.27M in Apr, 2025.

Who are the top competitors of Finnrick?

Finnrick's top competitors include Nordic Bioscience, BioAgilytix and Solvias. Among them, NCIMB secured the most recent funding round in April, 2025.

Finnrick - 2026 Company Profile & Competitors

Finnrick is an unfunded company based in Austin (United States). It operates as a Peptide testing and vendor rating service for public safety. Finnrick has not raised any funding yet. The company has 336 active competitors, including 15 funded and 84 that have exited. Its top competitors include companies like Nordic Bioscience, BioAgilytix and Solvias.

Company Details

Peptide testing and vendor rating service for public safety. It tests peptide products, scores vendors based on purity, quantity accuracy, and batch information, and publishes ratings. The company sources samples directly from vendors and uses HPLC testing to measure purity and quantity. It provides ratings for product/vendor pairs based on average score, minimum score, and number of tests conducted.

Key Metrics

Location

Austin, United States

Stage

Unfunded

Ranked

328^th among 336 active competitors

Similar Companies

Nordic Bioscience & 369 more

View Finnrick's full profile

Finnrick has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Finnrick include Nordic Bioscience, BioAgilytix and Solvias. Here is the list of Top 10 competitors of Finnrick, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nordic Bioscience 1996, Herlev (Denmark), Late Stage	Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform	-	KKR, Europa	62/100
2nd	BioAgilytix 2008, Durham (United States), Acquired	Global bioanalytical services leader, supporting drug development across various modalities	-	GHO Capital Partners, Caledonia Private Capital ... & 2 others	60/100
3rd	Solvias 1999, Kaiseraugst (Switzerland), Acquired	Developer and manufacturer of medical devices, cosmetics, agrochemicals, and chemicals	-	Water Street, Broadoak Capital Partners & 1 others	54/100
4th	Advion 1993, Ithaca (United States), Acquired	Mass spectrometry, chromatography, and purification solutions for scientific advancement	$45.6M	Aisling Capital, Polaris Partners & 3 others	50/100
5th	NCIMB 1982, United Kingdom, Early Stage	Provider of biorepository, microbial culture collection and microbiology services	$2.27M	The Scottish National Investment Bank, Maven Capital Partners ... & 2 others	49/100
6th	Alderley Analytical 2013, Stockport (United Kingdom), Acquired	Provider of bioanalytical services supporting drug development through pre-clinical and clinical stages	$869K	Northern Powerhouse Investment Fund, Pioneer Group ... & 3 others	49/100
7th	Kcas Bioanalytical Services 2014, Shawnee (United States), Acquired	Global bioanalytical CRO providing comprehensive drug development services and advanced assay capabilities	-	-	49/100
8th	NMS Labs 1970, Willow Grove (United States), Unfunded	Provider of bioanalytical and central lab services, with special expertise in clinical toxicology and forensic testing	-	-	48/100
9th	ImmunXperts 2014, Charleroi (Belgium), Acquired	CRO specializing in human immune system based bioassay development services	$1M	Biowin, Sambrinvest	48/100
10th	Nucro-Technics 1970, Scarborough (Canada), Acquired	Full-service bioanalytical CRO offering toxicity, bioanalytical and stability study services	-	-	46/100
328th	Finnrick Austin (United States), Unfunded	Peptide testing and vendor rating service for public safety	-	-	16/100